Investor Presentation - First Nine Months of 2016

Investor presentation First nine months of 2016 Slide 97 Novo Nordisk maintains leadership within human growth hormone (hGH) market Growth hormone volume market share Novo Nordisk Eli Lilly Pfizer Merck Kgaa Sandoz Roche 31% Development in global hGH market DKK billion MAT volume kg MAT value DKK kg 20 100 35% 30% 80 15 25% 60 CAGR volume¹: 4.7% 20% 10 CAGR value DKK¹: 1.8% 15% 40 10% 5 20 5% 0 Aug 2011 0 0% Aug 2016 Aug 2011 1 CAGR for 5-year period. Source: IMS Monthly MAT August, 2016 volume figures and value (DKK) figures changing diabetes® Source: IMS Monthly MAT August, 2016 volume figures Aug 2016 novo nordisk

View entire presentation